Showing results (691-700 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|November 15, 2019
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA ProtocolsMarta Sobas, Rebeca Rodriguez-Veiga, Edo Vellenga, et al.
European Journal of Haematology|November 17, 2019
Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma RegistryGöran Wålinder, Jan Samuelsson, Per Näsman, et al.
European Journal of Haematology|December 6, 2019
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab eraAntonio Gutierrez, Leyre Bento, Antonio Diaz-Lopez, et al.
European Journal of Haematology|November 26, 2019
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patientsElisabetta Antonioli, Chiara Nozzoli, Gabriele Buda, et al.
European Journal of Haematology|December 29, 2019
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myelomaRoman Hajek, Ludek Pour, Muhit Ozcan, et al.
European Journal of Haematology|December 16, 2019
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II resultJean-Marie Michot, Maxime Annereau, Alina Danu, et al.
European Journal of Haematology|December 17, 2019
Use of eltrombopag for patients 65 years old or older with immune thrombocytopeniaTomás José González-López, Blanca Sánchez-González, Isidro Jarque, et al.
European Journal of Haematology|December 20, 2019
Circulating extracellular vesicle-associated CD163 and CD206 in multiple myelomaSarah L Kvorning, Marlene C Nielsen, Niels F Andersen, et al.
European Journal of Haematology|March 4, 2020
Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myelomaEfrat Luttwak, Odelia Amit, Irit Avivi, et al.
Pageof 527